|
|
|||
|
|||
|
|
|||
|
hylaform |
|||
|
|
|||
|
|||
 
|
|||
|
|
|||
|
hylaform Generic Name: hylan B gel Date of Approval: October 13, 2004 Company: Inamed Corporation and Genzyme Corporation Treatment for: Wrinkle Correction The U.S hylaform. Food and Drug Administration (FDA) has approved Hylaform Plus (Hylan-Bgel), a large particle size hyaluronic acid-based dermal filler that is indicatedfor the correction of moderate to severe facial wrinkles and folds. Hylaform Plus was developed and is manufactured by Genzyme Corporation hylaform. Inamedis Genzyme's exclusive worldwide marketing and distribution partner for HylaformPlus hylaform. Hylaform Plus is a sterile, nonpyrogenic, viscoelastic, clear, colorless, transparentgel implant composed of cross-linked molecules of hyaluronan hylaform. Hyaluronan isa naturally occurring polysaccharide of the intercellular matrix in human tissues,including skin. Hylaform Plus is injected into the dermal tissue to provide a space-occupyingviscoelastic supplement for the intercellular matrix of the connective tissue hylaform. This viscosupplementation or augmentation of the dermal tissue can result inthe correction of skin contour deformities caused by wrinkles or folds. |
|||
 
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
| hhylaform hyylaform hyllaform hylaaform hylafform hylafoorm hylaforrm hylaformm ylaform hlaform hyaform hylform hylaorm hylafrm hylafom hylafor h ylaform hy laform hyl aform hyla form hylaf orm hylafo rm hylafor m hylaform yhlaform hlyaform hyalform hylfaorm hylaofrm hylafrom hylafomr ahylaform thehylaform hylaform | |||
|
|
|||
|
|
|||
|
|
|||
|
Copyright 2005 D-S LTD. |
